| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000030147 |
| Receipt No. | R000034432 |
| Official scientific title of the study | Modification of Neurotransmission of Brain-Gut Interactions |
| Date of disclosure of the study information | 2018/04/01 |
| Last modified on | 2017/11/28 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Modification of Neurotransmission of Brain-Gut Interactions | |
| Title of the study (Brief title) | Neuro-modification of Brain-Gut | |
| Region |
|
|
| Condition | ||||
| Condition | irritable bowel syndrome
healthy controls |
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The aim of this study is to test our hypothesis that brain-gut interactions in individuals with irritable bowel syndrome (IBS) is different from those in healthy controls. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | brain images of positron emission tomography (PET) |
| Key secondary outcomes | ordinate scale
psychometric tests plasma/serum hormones |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 6 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | saline
intravenous administration one time |
|
| Interventions/Control_2 | CRH
intravenous administration one time |
|
| Interventions/Control_3 | alpha-helical CRH
intravenous administration one time |
|
| Interventions/Control_4 | ramosetron
intravenous administration one time |
|
| Interventions/Control_5 | naloxone
intravenous administration one time |
|
| Interventions/Control_6 | asimadoline
intravenous administration one time |
|
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Rome III/IV
Asymptomatic healthy individual |
|||
| Key exclusion criteria | organic diseases
psychiatric diseases |
|||
| Target sample size | 240 | |||
| Research contact person | |
| Name of lead principal investigator | Shin Fukudo, MD, PhD |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Behavioral Medicine |
| Address | 2-1 Seiryo, Aoba, Sendai 980-8575, Japan |
| TEL | 022-717-8162 |
| sfukudo@med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Shin Fukudo, MD, PhD |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Behavioral Medicine |
| Address | 2-1 Seiryo, Aoba, Sendai 980-8575, Japan |
| TEL | 022-717-8162 |
| Homepage URL | |
| sfukudo@med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Department of Behavioral Medicine,
Tohoku University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | JSPS/MEXT
AMED/MHLW Institutional Grant |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東北大学大学院医学系研究科 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034432 |